Literature DB >> 17893458

Intramuscular injection of sevoflurane detects malignant hyperthermia predisposition in susceptible pigs.

Frank Schuster1, Thomas Metterlein, Sabrina Negele, Annegret Gardill, Ulrich Schwemmer, Norbert Roewer, Martin Anetseder.   

Abstract

BACKGROUND: The authors hypothesized that intramuscular sevoflurane injection allows diagnostic differentiation between malignant hyperthermia-susceptible (MHS) and -nonsusceptible (MHN) pigs by measurement of intramuscular lactate and carbon dioxide partial pressure (PCO2), and that dantrolene reduces the sevoflurane-induced PCO2 increase.
METHODS: With approval of the local animal care committee, microdialysis probes with attached microtubing for sevoflurane injection were placed in the adductor muscles of nine MHS and six MHN pigs, and PCO2 probes with microtubing were positioned in the triceps muscle of eight MHS and six MHN pigs. After equilibration, sevoflurane boluses at different concentrations and a sevoflurane-dantrolene bolus were injected synchronously. Lactate, pyruvate, and glucose as well as PCO2 were measured spectrophotometrically, and the rate of PCO2 increase was calculated.
RESULTS: Intramuscular sevoflurane injection increased local lactate and PCO2 dose dependently, and significantly higher in MHS than in MHN pigs. Measurement of the rate of PCO2 increase allowed a distinct differentiation between single MHS and MHN pigs. No significant increase in PCO2 was found with sevoflurane and dantrolene.
CONCLUSIONS: Local sevoflurane induces a hypermetabolic reaction measured by PCO2 and lactate increases. The reduced PCO2 increase in MHS after sevoflurane and dantrolene injection is likely to be a result of the sevoflurane-mediated calcium release and its antagonism by dantrolene. Sevoflurane may be useful for a less invasive diagnostic test for malignant hyperthermia in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17893458     DOI: 10.1097/01.anes.0000281915.85577.1a

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  3 in total

1.  [In-vivo diagnosis of malignant hyperthermia susceptibility: a microdialysis study].

Authors:  F Schuster; M Hager; T Metterlein; R M Muellenbach; T Wurmb; C Wunder; N Roewer; M Anetseder
Journal:  Anaesthesist       Date:  2008-08       Impact factor: 1.041

2.  Evaluation of suspected malignant hyperthermia events during anesthesia.

Authors:  Frank Schuster; Stephan Johannsen; Daniel Schneiderbanger; Norbert Roewer
Journal:  BMC Anesthesiol       Date:  2013-09-23       Impact factor: 2.217

3.  Metabolic effects as a cause of myotoxic effects of fluoroquinolones.

Authors:  Thomas Metterlein; Frank Schuster; Martin Hager; Norbert Roewer; Martin Anetseder
Journal:  Indian J Pharmacol       Date:  2015 Nov-Dec       Impact factor: 1.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.